Discover the CRTOH with its coordinators, Olivier Michielin and Mikaël Pittet
Patients, Clinicians, Scientists
The Translational Research Centre in Onco-Hematology (CRTOH), coordinated by Professors Mikael Pittet and Olivier Michielin, is dedicated to promoting translational and interdisciplinary cancer research that has the potential to quickly benefit patients. This involves a close collaboration between clinicians and researchers, and a proximity with the patients. The Centre also aims to promote the training of the next generation of researchers and clinicians focusing on translational cancer research.
The CRTOH comprises 40 research groups and more than 400 collaborators. Our ongoing research efforts are centered around several key areas, including tumor immunology and immunotherapy, precision oncology, cell division and cancer, and cancer pharmacology.
Latest News
[REPLAY] Cancer: understanding the disease to fight it more effectively
“The biggest hurdle to get there is actually not technical – it’s really regulatory.”
Brain cancer: Immunotherapy first, surgery afterwards
Acute myeloid leukemias: cancer cells grow more aggressive without new mutations
Why Moderna’s vaccine is being hailed as a ‘revolution’ in the fight against cancer